Biological Therapy in Treating Patients With Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

August 31, 2008

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

therapeutic autologous lymphocytes

Trial Locations (1)

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00045357 - Biological Therapy in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter